05.01.2023 | Tracker

Top 50 Pharma Tracker: HCPs celebrate the Moderna and Merck combination melanoma vaccine and immunotherapy

By Francesca Gan

Discover what healthcare professionals (HCPs) think about pharmaceutical products and their manufacturers, as it happens, through CREATION.co’s tracking updates. How are HCPs responding to drug launch news? How are HCPs talking about or engaging with the Top 50 pharma companies on social media? Each week, CREATION.co’s tracking updates bring you the latest insights from the conversation of HCPs across the globe discussing these topics and more.

The Top 50 Pharmaceutical Companies mentioned by HCPs on Twitter

December RankNovember RankCompany
Name
Total
Mentions
Account
Mentions
Account
Retweets
11Pfizer3,52829114
23Moderna1,498390
34Johnson & Johnson48921824
45AstraZeneca4701375
518Biogen3152030
66GSK2968820
717Eisai2942180
88Novo Nordisk26923110
97Roche2226912
1010Sanofi22114117
1111Novartis1901205
122Lilly1841460
1320Gilead Sciences182717
1416Merck & Co155560
1514Abbott1291213
1629Teva12812339
1719Amgen121789
1823BMS1151050
1913Bayer1104411
209AbbVie104802
2112Takeda100811
2215Boehringer Ingelheim85510
2321Fresenius60520
2422Otsuka4441
2533Stada3300
2635Regeneron3280
2726Servier2782
2824Organon2400
2930Daiichi Sankyo2371
3025Merck KGaA22176
3134CSL16134
3236UCB14121
3332Astellas1482
3427Ipsen1340
3538Bausch1100
3628Vertex1090
3740Grifols900
3837Menarini822
3939Alexion840
4031Viatris730
4142Jazz Pharmaceuticals600
4244CSPC400
4241Kyowa Kirin200
4445Sun210
4542Aurobindo100
5050Jiangsu Hengrui000
5050Endo000
5050Sino000
5050Shanghai000
5050Sumitomo Dainippon000

The latest insights from HCPs mentioning the Top 50 Pharmaceutical Companies

The five pharmaceutical companies that were mentioned the most by healthcare professionals (HCPs) on Twitter in December 2022 were Pfizer, Moderna, Johnson & Johnson, AstraZeneca and Biogen.

CREATION.co identified 8,279 HCP mentions of pharmaceutical companies online in December 2022, decreasing over 40% from the previous month. This was largely due to a quieter online presence by HCPs over the Christmas holidays.

One driver of conversation by HCPs in December 2022 was the release of trial results of the combination Moderna cancer vaccine and Merck immunotherapy for patients with stage 3 or 4 melanoma. HCPs heralded the results, with Dr Eric Ding calling it a ‘cancer breakthrough’

Dr. Eric Topol also highlighted the trial results, celebrating that it was ‘superior to immunotherapy alone’:

The top shared links by HCPs discussed:

 

  1. An article Dr Eddy Betterman’s website discussing Pfizer’s paxlovid and its adverse effects.
  2. A press release by Novartis on the trial results of Pluvicto.
  3. A PDF document, ‘Cumulative Analysis of Post-authorization Adverse Event Reports’ by Pfizer.

 

HCPs also discussed the congressional report discussing the FDA’s accelerated approval of Biogen’s aducanamab, which led to their jump into 5th most discussed pharmaceutical company in December 2021. 

CREATION.co continues to analyse online HCP conversation on a variety of topics including virtual congress, healthcare changes since the pandemic, product development and therapy area specific insights.

 

To stay up to date, you can sign up to CREATION.co’s monthly eJournal.

 

Methodology notes:

    • In December 2022, CREATION Pinpoint® identified 8,279 healthcare professional authored tweets from 3,702 individual HCPs mentioning a Top 50 Pharmaceutical company (according to revenue). 
    • Data for this research was analysed from the online Twitter conversations of HCPs in all languages mentioning a Top 50 Pharmaceutical company between 01 December and 31 December 2022.
  • Unless otherwise specified, mentions of a company are not limited to its Twitter account(s).
  • In some cases, a tweet may mention more than one company account (e.g. @abbottnews and @abbottglobal) – this only counts as one Company Mention and Account Mention.
  • Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Janssen. In December 2022, 72 of these posts mentioned Janssen.

The Top 50 Pharma tracker archive

October 2022: HCPs actively discussed issues concerning mRNA and bivalent COVID-19 vaccines

Top 50 Table

Top 50 Insights

September 2022: Top 50 Pharma Tracker: Bivalent vaccine data and new treatments drive HCP conversation

Top 50 Table

Top 50 Insights

August 2022: Top 50 Pharma Tracker: HCPs discuss bivalent vaccine approval in the UK and advances in obesity treatment.

Top 50 Table
Top 50 Insights

July 2022: Top 50 Pharma Tracker: HCPs continue to discuss Moderna’s COVID-19 vaccine but mentions of Pfizer dramatically decrease

Top 50 Table
Top 50 Insights

June 2022: Top 50 Pharma Tracker: HCPs share mixed opinions on COVID-19 vaccines and treatment data

Top 50 Table
Top 50 Insights

May 2022: Top 50 Pharma Tracker: HCPs discuss Pfizer vaccine documents and share opinions on COVID-19 vaccine efficacy.

Top 50 Table
Top 50 Insights

April 2022: HCPs celebrate the success of Lilly’s tirzepatide for obesity and discuss COVID-19 vaccine efficacy

Top 50 Table
Top 50 Insights

March 2022: HCPs compare immune responses of T cell, B cell, and Antibodies to different COVID-19 vaccines.

Top 50 Table
Top 50 Insights

February 2022: HCPs discuss Healthcare inequity and vaccination of under 5 year olds

Top 50 Table
Top 50 Insights

January 2022: HCPs get political when discussing Regeneron’s COVID-19 treatment

Top 50 Table
Top 50 Insights

December 2021: Omicron variant dominates HCP conversation in December 2021

Top 50 Table
Top 50 Insights

November 2021 : HCPs discuss trial data of Pfizer’s COVID-19 booster vaccine and oral treatment

Top 50 Table
Top 50 Insights

October 2021 : Pfizer most discussed company with booster and children’s COVID-19 jabs

Top 50 Table
Top 50 Insights

July 2021: HCPs discuss “booster shot” to decrease the high spread of the Delta variant

Top 50 Table
Top 50 Insights

June 2021: HCPs discuss effectiveness of COVID-19 vaccines against delta strain.

Top 50 Table
Top 50 Insights

May 2021: HCPs discuss accessibility of COVID-19 treatments globally.

Top 50 Table
Top 50 Insights

April 2021: HCPs reassure the public as they discuss COVID-19 vaccine side effects.

Top 50 Table
Top 50 Insights

March 2021: Oxford-AstraZeneca vaccine provokes HCP conversation as they discuss blood clots as a side effect.

Top 50 Table
Top 50 Insights

February 2021: J&J FDA approval of single-dose vaccine stirs HCP conversations

Top 50 Table
Top 50 Insights

January 2021: J&J new vaccine data drives increase in company posts online

Top 50 Table
Top 50 Insights

December 2020: COVID-19 makes up 84% of total conversation

Top 50 Table
Top 50 Insights

November 2020: Vaccine success dwarfs all other conversation.

Top 50 Table
Top 50 Insights

October 2020: Regeneron tops list due to high profile COVID-19 treatment conversation.

Top 50 Table
Top 50 Insights

September 2020: ASTRAZENECA’S VACCINE TRIAL SAFETY DISCUSSED BUT TRANSPARENCY IS CELEBRATED.

Top 50 Table
Top 50 Insights

August 2020: HCPS DISCUSS ASTRAZENECA MORE THAN GILEAD FOR FIRST TIME SINCE PANDEMIC

Top 50 Table
Top 50 Insights

July 2020: COVID-19 CANDIDATES TAKE OVER ALL HCP CONVERSATION

Top 50 Table
Top 50 Insights

June 2020: HCPs respond to COVID-19 treatment options

Top 50 Table
Top 50 Insights

May 2020: HCPs track pharma covid-19 developments online

Top 50 Table
Top 50 Insights

April 2020: HCPS RESPOND TO PHARMA COVID-19 ACTIVITY

Top 50 Table
Top 50 Insights

March 2020: HCPS MENTIONING PHARMA IN RELATION TO COVID-19

Top 50 Table
Top 50 Insights

February 2020: HCPS DISCUSS GILEAD, EISAI AND MERCK & CO’S TRIAL RESULTS

Top 50 Table
Top 50 Insights

January 2020: NEW YEAR BEGINS WITH FAILED TRIALS AND SUCCESSFUL PODCAST LAUNCH

Top 50 Table
Top 50 Insights

December 2019: @NOVARTIS MOST MENTIONED TWITTER ACCOUNT FOR SECOND MONTH

Top 50 Table
Top 50 Insights

November 2019: GILEAD INTO TOP 5 AFTER PRICE DISCREPANCY

Top 50 Table
Top 50 Insights

October 2019: HCPS ENGAGE WITH TOP 50 PHARMA AROUND GOOD AND BAD NEWS

Top 50 Table
Top 50 Insights

September 2019: HCPS ENGAGED MEANINGFULLY WITH TOP 50 PHARMA

Top 50 Table
Top 50 Insights

August 2019: #WHATHCPSTHINK ABOUT THE TOP 50 PHARMA

Top 50 Table
Top 50 Insights

View all articles >

Meet the Author

Francesca Gan

Fran analyses the unprompted online conversations of healthcare professionals to produce actionable insights for clients. Her background in legal research provides a solid foundation in critical thinking and enables a well rounded approach to her data research.

Fran has a keen interest in netball and is a big follower of the New Zealand domestic netball league. She is also a lover of board games and card games, especially ones that involve shouting!

Suggested next


HCP social media research to support you during COVID-19

19.05.2020 | Article

HCP social media research to support you during COVID-19

The COVID-19 pandemic has radically shifted how we are working and communicating with each o

By Luke Wilson

02.12.2020 | Article

Vaccine efficacies dominate news, and HCPs support calls for robust public health roll out strategies

Discover what healthcare professionals (HCPs) think about COVID-19 vaccines

By Aaron Pitkin

View all articles >